Higher maternal doses of methadone does not increase neonatal abstinence syndrome

Tallennettuna:

Bibliografiset tiedot
Päätekijä:	Pizarro, D.
Muut tekijät:	ET AL
Aineistotyyppi:	Kirja
Kieli:	espanja englanti
Aiheet:	Dosis Drogas ilegales Drogodependencias Efectos Efectos no deseados Embarazo Hijos Infancia Madre Metadona Mujer Opiáceos Programas de mantenimiento Recién nacido Reducción de daños Síndrome de abstinencia Tratamiento médico Adicciones Género y familia Menores Documental
Linkit:	DOI Path
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia: Higher maternal doses of methadone does not increase neonatal abstinence syndrome

Pikavilkaisu
NEONATAL ABSTINENCE SYNDROME AFTER MATERNAL METHADONE TREATMENT
Pikavilkaisu
METHADONE DOSE AND NEONATAL ABSTINENCE SYNDROME. SYSTEMATIC REVIEW AND META ANALYSIS
Pikavilkaisu
PROMOTING ABSTINENCE FROM COCAINE AND HEROIN WITH A METHADONE DOSE INCREASE AND A NOVEL CONTINGENCY
Pikavilkaisu
INFANT AUTONOMIC FUNCTIONING AND NEONATAL ABSTINENCE SYNDROME
Pikavilkaisu
NEONATAL WITHDRAWAL SYNDROME IN INFANTS EXPOSED TO COCAINE AND METHADONE
Pikavilkaisu
OPIOID MAINTENACE TREATMENT DURING PREGNANCY: OCCURRENCE AND SEVERITY OF NEONATAL ABSTINENCE SYNDROME
Pikavilkaisu
Methadone dosing and prescribed medication use in a prospective cohort of opioid-dependent pregnant women
Pikavilkaisu
METHADONE, MAINTENANCE VS. METHADONE TAPER DURING PREGNANCY: MATERNAL AND NEONATAL OUTCOMES
Pikavilkaisu
METHADONE, MAINTENANCE VS. METHADONE TAPER DURING PREGNANCY: MATERNAL AND NEONATAL OUTCOMES
Pikavilkaisu
NEONATAL ABSTINENCE SYNDROME DUE TO CODEINE
Pikavilkaisu
CAN METHADONE CONCENTRATIONS PREDICT THE SEVERITY OF WITHDRAWAL IN INFANTS AT RISK OF NEONATAL ABSTINENCE SYNDROME?
Pikavilkaisu
HYPERPHAGIA IN NEONATES WITHDRAWING FROM METHADONE
Pikavilkaisu
BUPRONORPHINE VERSUS METHADONE IN THE TREATMENT OF PREGNANT OPIOID-DEPENDENT PATIENTS: EFFECTS ON THE NEONATAL ABSTINENCE SYNDROME
Pikavilkaisu
NEONATAL WITHDRAWAL FROM MATERNAL VOLATILE SUBSTANCE ABUSE
Pikavilkaisu
REVISED DOSE SCHEMA OF SUBLINGUAL BUPRENORPHINE IN THE TREATMENT OF THE NEONATAL OPIOID ABSTINENCE SYNDROME
Pikavilkaisu
Neonatal abstinence syndrome after intrauterine opioid exposure: Standards, cost-effectiveness of treatment and maternal rights
Pikavilkaisu
Methadone dose as a determinant of infant outcome during the peri and postnatal period
Pikavilkaisu
The economic burden of neonatal abstinence syndrome in the United States
Pikavilkaisu
NEONATAL ABSTINENCE SYNDROME IN METHADONE-EXPOSED INFANTS IS ALTERED BY LEVEL OF PRENATAL TOBACCO EXPOSURE
Pikavilkaisu
TREATMENT OF NEONATAL ABSTINENCE SYNDROME
Pikavilkaisu
MANAGEMENT OF NEONATAL ABSTINENCE SYNDROME IN NEONATES BORN TO OPIOID MAINTAINED WOMEN
Pikavilkaisu
THERAPY OF THE NEONATAL ABSTINENCE SYNDROME WITH TINCTURE OF OPIUM OR MORPHINE DROPS
Pikavilkaisu
OPTIMIZING RESPONSE TO METHADONE MAINTENANCE TREATMENT: USE OF HIGHER-DOSE METHADONE
Pikavilkaisu
Diagnosis of neonatal abstinence syndrome: substance use during pregnancy